E-ISSN 2149-2018 editor@ejmamr.online


Applied Medical Research. 2015; 1(1):(6-107)


Design and characterization of microsponge loaded controlled release epicutaneous gel of lornoxicam

Purnima Panday, Neha Shukla, Dharmesh Sisodiya, Vikas Jain, Suresh Chand Mahajan

Abstract

Aim: Transdermal delivery, a successful novel approach aimed at achieving systematically active level of drug. The work involves the drug lornoxicam is a non-steroidal anti-inflammatory drug bearing analgesic, antiinflammatory, and antipyretic property. The micro sponge technology used to facilitate the controlled release of active drug into the skin in order to reduce the systematic exposure and minimize local cutaneous reactions of active drugs. The main objective of this work was to design and evaluate the gel formation of microsponge entrapped lornoxicam to increase the effectiveness of the treatment. Materials and Methods: The microsponges were prepared by quasi emulsion solvent diffusion method. The internal phase consisting eudragit RS-100 and ethyl cellulose dissolved in dichloromethane and ethyl alcohol, drug is slowly added to polymer solution with continuous stirring for 4 h, and then mixture was filtered to separate the microsponges. Microsponges was characterized by parameters like scanning electron microscopy, drug content, particle size analysis, compatibility studies using differential scanning calorimetry. Microsponge-loaded gel was characterized by physical parameters of gel, measurement of PH, viscosity study, Drug content study, in-vitro release studies using first order kinetics, Higuchi Model, Peppas release Model. Results: The different kinetics models showed that the release data followed Higuchi matrix and the release mechanism from microsponges was diffusion. Conclusion: From the results, it can be concluded that LMF3 formulation shows drug release in a controlled manner.

Most Viewed Article
  • Non-compliance with Wearing Facemasks thru Pandemics: Reappraisal of Interconnected Dynamics
    Saeed Shoja Shafti
    » Abstract » doi: 10.5455/amr.20211030

  • Optokinetic Stimulation as a Treatment for Parkinson’s Disease
    Quinn Hanses1 and Anna Rose Wiencek*2
    » Abstract » doi: 10.5455/amr.20211029

  • Outbreaks of Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2) in Comorbid Patients
    Kaiser Jamil1*, Kavita Kumari Kakarala1 and Ramesh Maturi2
    » Abstract » doi: 10.5455/amr.20211027

  • Knowledge, Attitude and Practice of Covid-19 Prevention and Associated Factors among House Holds In Ilu Ababor and Bunno Bedele Zones, Southwest Ethiopia: A Cross-Sectional Study
    Milkias Dugassa1*, Bonsa Amsalu1, Sanbato Tamiru1, Ebissa Negera2, Abdi Gada2, Tesfaye Tsegaye3, Firomsa Bekele3, Desalegn Chilo3, Mustefa Mohammedhussein4, Endegena Abebe5 and Eshetu Chilo5
    » Abstract » doi: 10.5455/amr.20211028

  • Outbreaks of Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2) in Comorbid Patients
    Kaiser Jamil1*, Kavitha Kumari Kakarala1 and Ramesh Maturi2
    » Abstract » doi: 10.5455/amr.20211027

Most Downloaded
  • Non-compliance with Wearing Facemasks thru Pandemics: Reappraisal of Interconnected Dynamics
    Saeed Shoja Shafti
    » Abstract » doi: 10.5455/amr.20211030

  • Optokinetic Stimulation as a Treatment for Parkinson’s Disease
    Quinn Hanses1 and Anna Rose Wiencek*2
    » Abstract » doi: 10.5455/amr.20211029

  • Outbreaks of Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2) in Comorbid Patients
    Kaiser Jamil1*, Kavita Kumari Kakarala1 and Ramesh Maturi2
    » Abstract » doi: 10.5455/amr.20211027

  • Knowledge, Attitude and Practice of Covid-19 Prevention and Associated Factors among House Holds In Ilu Ababor and Bunno Bedele Zones, Southwest Ethiopia: A Cross-Sectional Study
    Milkias Dugassa1*, Bonsa Amsalu1, Sanbato Tamiru1, Ebissa Negera2, Abdi Gada2, Tesfaye Tsegaye3, Firomsa Bekele3, Desalegn Chilo3, Mustefa Mohammedhussein4, Endegena Abebe5 and Eshetu Chilo5
    » Abstract » doi: 10.5455/amr.20211028

  • Outbreaks of Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2) in Comorbid Patients
    Kaiser Jamil1*, Kavitha Kumari Kakarala1 and Ramesh Maturi2
    » Abstract » doi: 10.5455/amr.20211027